COVID-19 caused significant morbidity and mortality amongst ethnic minority groups, but vaccine uptake remained lower than non-minoritised groups. Interventions to increase vaccine uptake among ethnic minority communities are crucial. This systematic review synthesises and evaluates behaviour change techniques (BCTs) in interventions to increase vaccination uptake in ethnic minority populations. We searched five databases and grey literature sources. From 7637 records identified, 23 studies were included in the review. Interventions were categorised using the Behaviour Change Wheel (BCW) and Behaviour Change Taxonomy v1. Vaccines included influenza, pertussis, tetanus, diphtheria, meningitis and hepatitis. Interventions were primarily delivered in health centres/clinics and community settings. Six BCW intervention functions and policy categories and 26 BCTs were identified. The main intervention functions used were education, persuasion and enablement. Overall, effective interventions had multi-components and were tailored to specific populations. No strong evidence was observed to recommend specific interventions, but raising awareness and involvement of community organisations was associated with positive effects. Several strategies are used to increase vaccine uptake among ethnic minority communities; however, these do not address all issues related to low vaccine acceptance. There is a strong need for an increased understanding of addressing vaccine hesitancy among ethnic minority groups.
Background/Objectives: Healthcare workers (HCWs) have a crucial role in addressing vaccine hesitancy in ethnic minority populations as they are a trusted source of information. The aim of this systematic review is to synthesise and evaluate behaviour change techniques (BCTs) and strategies in interventions aimed at HCWs to promote vaccine uptake among ethnic minority populations. Methods: The literature was systematically searched in peer-reviewed databases and the grey literature. Studies were included if they reported interventions for respiratory and routinely recommended vaccine-preventable diseases which were delivered by HCWs to increase vaccine uptake in ethnic minority groups. Interventions were coded using the Behaviour Change Wheel (BCW) and BCT Taxonomy. Results: From 7250 records identified, 14 studies were included in the review. Vaccines targeted by interventions included influenza, pneumococcal disease, pertussis, tetanus, diphtheria, meningitis and hepatitis B. Seven BCW intervention types, six policy options and 22 BCTs were identified. Main intervention types used were persuasion, enablement and education. Effective interventions had multi-components and were tailored to specific populations. Staff training to improve vaccine recommendation and dialogue with patients, and prompts/cues were associated with positive effects, but there was no strong evidence to recommend one specific intervention strategy over another as effectiveness was linked to a multitude of BCTs and intervention types. Conclusions: Several strategies aimed at HCWs can be used and tailored to increase vaccine uptake among ethnic minority communities; however, this does not address all issues related to low vaccine uptake. While HCWs are necessary, without system-level enablement, they cannot fully address barriers to vaccine uptake.
Objective: To examine the comorbid occurrence of diabetes and depression with clinical CVD endpoints, by conducting a systematic review and meta-analysis of observational studies. Research Design and Methods: We searched PUBMED/MEDLINE, Medscape, Cochrane Library, CINAHL, EMBASE and Scopus databases assessing cardiac events and mortality associated with depression in diabetes up until 1 December 2018. Pooled hazard ratios were calculated using random- effects models. Results: Nine studies met the inclusion criteria. The combined pooled hazard ratios all showed a significant risk of cardiac events in people with depression and type 2 diabetes, compared to those with type 2 diabetes alone. For cardiovascular mortality the pooled hazard ratio was 1.48 (95% CI: 1.185, 1.845), p=0.001, for coronary heart disease 1.37 (1.165, 1.605), p<0.001 and for stroke 1.33 (1.291, 1.369), p<0.001. Heterogeneity was high in the meta-analysis for stroke events (I-squared = 84.7%) but was lower for coronary heart disease and cardiovascular mortality (15% and 43.4% respectively). Meta-regression analyses showed the impact of depression was not significantly associated with the study level covariates mean age, duration of diabetes, length of follow-up, BMI, sex and ethnicity (p<0.05 for all models). Only three studies were found that examined the association of depression in type 1 diabetes, there was a high degree of heterogeneity and data synthesis was not conducted for these studies. Conclusions: We have demonstrated a 47.9% increase in cardiovascular mortality, 36.8% increase in coronary heart disease and 32.9% increase in stroke in people with diabetes and comorbid depression. The presence of depression in a person with diabetes should trigger the consideration of evidence-based therapies for cardiovascular disease prevention irrespective of the baseline risk of cardiovascular disease or duration of diabetes. Funding Statement: The authors state: "None." Declaration of Interests: The authors stated: "None relevant to declare." Ethics Approval Statement: No separate ethical approval was required for the conduct of this study, as any necessary ethical approval was obtained for each of the individual studies contributing data to the meta-analysis. The authors conducted this literature-based review using a protocol registered in the PROSPERO International prospective register of systematic reviews (ID=CRD42017083968) and in accordance with guidelines of PRISMA.